| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Digestive System Abnormalities | 3 | 2019 | 38 | 1.470 |
Why?
|
| Tomography, X-Ray Computed | 22 | 2023 | 7551 | 1.440 |
Why?
|
| Calcinosis | 4 | 2019 | 423 | 1.240 |
Why?
|
| Pancreatic Diseases | 2 | 2018 | 108 | 1.150 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2021 | 35 | 0.790 |
Why?
|
| Pancreatic Neoplasms | 9 | 2022 | 5061 | 0.770 |
Why?
|
| Radiography, Interventional | 4 | 2011 | 305 | 0.740 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2020 | 54 | 0.710 |
Why?
|
| Uterine Neoplasms | 2 | 2023 | 545 | 0.700 |
Why?
|
| Abdomen | 2 | 2021 | 332 | 0.680 |
Why?
|
| Oncogenic Viruses | 1 | 2018 | 18 | 0.670 |
Why?
|
| Bile Duct Diseases | 1 | 2019 | 45 | 0.670 |
Why?
|
| Ovarian Neoplasms | 5 | 2023 | 4638 | 0.610 |
Why?
|
| Cysts | 1 | 2019 | 197 | 0.610 |
Why?
|
| Endometrial Neoplasms | 3 | 2023 | 1341 | 0.600 |
Why?
|
| Tumor Virus Infections | 1 | 2018 | 224 | 0.590 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2024 | 7702 | 0.590 |
Why?
|
| Bone Neoplasms | 2 | 2024 | 2576 | 0.560 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2018 | 362 | 0.550 |
Why?
|
| Pancreatitis | 1 | 2018 | 267 | 0.520 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2021 | 1833 | 0.520 |
Why?
|
| Catheter Ablation | 3 | 2011 | 620 | 0.520 |
Why?
|
| Pancreatectomy | 2 | 2019 | 652 | 0.490 |
Why?
|
| Tenosynovitis | 1 | 2014 | 14 | 0.490 |
Why?
|
| Wrist Joint | 1 | 2014 | 30 | 0.480 |
Why?
|
| Adrenal Gland Neoplasms | 4 | 2020 | 489 | 0.480 |
Why?
|
| Ankle Joint | 1 | 2014 | 33 | 0.470 |
Why?
|
| Arthritis, Juvenile | 1 | 2014 | 51 | 0.470 |
Why?
|
| Diagnosis, Differential | 12 | 2020 | 4744 | 0.440 |
Why?
|
| Multiple Myeloma | 1 | 2024 | 2138 | 0.430 |
Why?
|
| Contrast Media | 6 | 2020 | 1472 | 0.390 |
Why?
|
| Liver Neoplasms | 5 | 2020 | 4557 | 0.390 |
Why?
|
| Humans | 56 | 2024 | 261506 | 0.340 |
Why?
|
| Catheterization | 1 | 2011 | 410 | 0.340 |
Why?
|
| Kidney Neoplasms | 4 | 2013 | 3022 | 0.330 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2020 | 361 | 0.300 |
Why?
|
| Radiographic Image Enhancement | 2 | 2020 | 402 | 0.290 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 10035 | 0.260 |
Why?
|
| Peritoneal Neoplasms | 2 | 2023 | 821 | 0.260 |
Why?
|
| Hepatic Artery | 3 | 2017 | 240 | 0.250 |
Why?
|
| Liver | 5 | 2020 | 2961 | 0.250 |
Why?
|
| Radiologists | 3 | 2022 | 163 | 0.250 |
Why?
|
| Osteosarcoma | 1 | 2011 | 929 | 0.240 |
Why?
|
| Female | 28 | 2023 | 141928 | 0.240 |
Why?
|
| Peritoneum | 2 | 2020 | 150 | 0.230 |
Why?
|
| Whole Body Imaging | 1 | 2024 | 114 | 0.220 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2020 | 1226 | 0.220 |
Why?
|
| Liver Cirrhosis, Experimental | 2 | 2013 | 18 | 0.220 |
Why?
|
| Radionuclide Imaging | 1 | 2024 | 660 | 0.220 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2023 | 82 | 0.220 |
Why?
|
| Diagnostic Imaging | 5 | 2023 | 1162 | 0.210 |
Why?
|
| Liver Diseases | 2 | 2018 | 574 | 0.210 |
Why?
|
| Adrenocortical Adenoma | 1 | 2020 | 22 | 0.180 |
Why?
|
| Neoplasm Staging | 10 | 2021 | 13658 | 0.180 |
Why?
|
| Endometrium | 1 | 2023 | 470 | 0.180 |
Why?
|
| Neoplasms | 3 | 2023 | 15193 | 0.180 |
Why?
|
| Hemangioendothelioma, Epithelioid | 1 | 2020 | 39 | 0.180 |
Why?
|
| Digestive System Neoplasms | 1 | 2020 | 82 | 0.180 |
Why?
|
| Radiography, Abdominal | 1 | 2020 | 120 | 0.170 |
Why?
|
| Image Enhancement | 1 | 2023 | 561 | 0.170 |
Why?
|
| Pancreatitis, Chronic | 1 | 2020 | 116 | 0.170 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2011 | 2326 | 0.170 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2023 | 486 | 0.170 |
Why?
|
| Aged | 15 | 2021 | 70117 | 0.160 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2020 | 1724 | 0.160 |
Why?
|
| Spleen | 1 | 2020 | 676 | 0.160 |
Why?
|
| Neoadjuvant Therapy | 2 | 2022 | 4975 | 0.160 |
Why?
|
| Retrospective Studies | 14 | 2023 | 37905 | 0.160 |
Why?
|
| Aged, 80 and over | 11 | 2020 | 29902 | 0.160 |
Why?
|
| Catheters, Indwelling | 1 | 2020 | 374 | 0.150 |
Why?
|
| Infusions, Intra-Arterial | 3 | 2013 | 171 | 0.150 |
Why?
|
| Catheterization, Central Venous | 1 | 2020 | 354 | 0.150 |
Why?
|
| Portal System | 1 | 2017 | 34 | 0.150 |
Why?
|
| Embolization, Therapeutic | 2 | 2013 | 551 | 0.150 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2018 | 132 | 0.150 |
Why?
|
| Preoperative Care | 2 | 2020 | 1529 | 0.150 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2020 | 833 | 0.150 |
Why?
|
| Thoracic Neoplasms | 1 | 2020 | 337 | 0.150 |
Why?
|
| Coinfection | 1 | 2018 | 189 | 0.140 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2018 | 317 | 0.140 |
Why?
|
| Laser Therapy | 2 | 2012 | 411 | 0.140 |
Why?
|
| Hypercalcemia | 1 | 2017 | 137 | 0.140 |
Why?
|
| Prognosis | 7 | 2023 | 21713 | 0.140 |
Why?
|
| Documentation | 1 | 2017 | 207 | 0.130 |
Why?
|
| Bile Duct Neoplasms | 1 | 2020 | 493 | 0.130 |
Why?
|
| Cholangiocarcinoma | 1 | 2020 | 493 | 0.130 |
Why?
|
| Chemoradiotherapy | 2 | 2022 | 1946 | 0.130 |
Why?
|
| Intestinal Neoplasms | 1 | 2017 | 189 | 0.130 |
Why?
|
| Ultrasonography, Doppler | 1 | 2016 | 231 | 0.130 |
Why?
|
| Breast Implantation | 1 | 2018 | 228 | 0.130 |
Why?
|
| Middle Aged | 16 | 2022 | 86204 | 0.130 |
Why?
|
| Carcinoma, Small Cell | 1 | 2017 | 408 | 0.130 |
Why?
|
| Radiology | 1 | 2020 | 434 | 0.130 |
Why?
|
| Population Surveillance | 1 | 2018 | 627 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 671 | 0.120 |
Why?
|
| Biopsy, Needle | 2 | 2008 | 1363 | 0.120 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2018 | 387 | 0.120 |
Why?
|
| Ganglioneuroma | 1 | 2013 | 41 | 0.120 |
Why?
|
| Balloon Occlusion | 1 | 2013 | 49 | 0.120 |
Why?
|
| Male | 16 | 2022 | 123000 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 6009 | 0.110 |
Why?
|
| Gadolinium DTPA | 1 | 2014 | 172 | 0.110 |
Why?
|
| Vascular Access Devices | 1 | 2013 | 51 | 0.110 |
Why?
|
| Breast Implants | 1 | 2018 | 391 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2018 | 4971 | 0.110 |
Why?
|
| Ethanol | 2 | 2013 | 264 | 0.110 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 550 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2017 | 363 | 0.110 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2018 | 716 | 0.110 |
Why?
|
| Duodenum | 1 | 2013 | 149 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 651 | 0.100 |
Why?
|
| Nanocapsules | 1 | 2012 | 28 | 0.100 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 715 | 0.100 |
Why?
|
| Iodized Oil | 1 | 2011 | 6 | 0.100 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2013 | 204 | 0.100 |
Why?
|
| Cryosurgery | 1 | 2013 | 167 | 0.100 |
Why?
|
| Chyle | 1 | 2011 | 10 | 0.100 |
Why?
|
| Treatment Outcome | 9 | 2018 | 32848 | 0.100 |
Why?
|
| Genital Neoplasms, Female | 1 | 2018 | 735 | 0.100 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2013 | 255 | 0.100 |
Why?
|
| Adult | 11 | 2020 | 77950 | 0.100 |
Why?
|
| Neuroendocrine Tumors | 1 | 2017 | 634 | 0.090 |
Why?
|
| Hypertension, Portal | 1 | 2011 | 124 | 0.090 |
Why?
|
| Stomach | 1 | 2013 | 387 | 0.090 |
Why?
|
| Pelvis | 2 | 2023 | 362 | 0.090 |
Why?
|
| Angiography | 1 | 2011 | 360 | 0.090 |
Why?
|
| Paclitaxel | 2 | 2019 | 1996 | 0.090 |
Why?
|
| Extremities | 1 | 2011 | 303 | 0.090 |
Why?
|
| Positron-Emission Tomography | 1 | 2018 | 2173 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 14289 | 0.080 |
Why?
|
| Adipose Tissue | 1 | 2013 | 769 | 0.080 |
Why?
|
| Mediastinal Diseases | 1 | 2008 | 56 | 0.080 |
Why?
|
| Pleural Diseases | 1 | 2008 | 57 | 0.080 |
Why?
|
| Urinary Bladder | 1 | 2011 | 575 | 0.080 |
Why?
|
| Young Adult | 5 | 2020 | 21445 | 0.080 |
Why?
|
| Equipment Design | 3 | 2020 | 1204 | 0.080 |
Why?
|
| Cytodiagnosis | 1 | 2008 | 220 | 0.080 |
Why?
|
| Endovascular Procedures | 1 | 2013 | 516 | 0.070 |
Why?
|
| Neoplasms, Experimental | 1 | 2010 | 750 | 0.070 |
Why?
|
| Heart Failure | 1 | 2020 | 2516 | 0.070 |
Why?
|
| Algorithms | 1 | 2017 | 3890 | 0.070 |
Why?
|
| Ultrasonography, Interventional | 1 | 2008 | 429 | 0.070 |
Why?
|
| Risk Factors | 3 | 2018 | 17523 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 4654 | 0.060 |
Why?
|
| Adolescent | 5 | 2020 | 31252 | 0.060 |
Why?
|
| Melanoma | 1 | 2021 | 5317 | 0.060 |
Why?
|
| Stomach Neoplasms | 1 | 2017 | 2278 | 0.060 |
Why?
|
| Toes | 1 | 2023 | 46 | 0.060 |
Why?
|
| Venous Pressure | 2 | 2013 | 16 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2008 | 717 | 0.050 |
Why?
|
| Biopsy | 3 | 2018 | 3443 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2018 | 5542 | 0.050 |
Why?
|
| Sus scrofa | 2 | 2013 | 169 | 0.050 |
Why?
|
| Microspheres | 2 | 2013 | 210 | 0.050 |
Why?
|
| Laparoscopy | 1 | 2011 | 1225 | 0.050 |
Why?
|
| Infant | 2 | 2014 | 13310 | 0.050 |
Why?
|
| Lymphatic Metastasis | 2 | 2021 | 4844 | 0.050 |
Why?
|
| Mucous Membrane | 1 | 2021 | 271 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 7789 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2014 | 16273 | 0.050 |
Why?
|
| Mesentery | 1 | 2020 | 72 | 0.050 |
Why?
|
| Iohexol | 1 | 2020 | 58 | 0.050 |
Why?
|
| Artifacts | 1 | 2023 | 532 | 0.050 |
Why?
|
| Genitalia, Female | 1 | 2020 | 68 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 15862 | 0.050 |
Why?
|
| Injections | 1 | 2020 | 285 | 0.050 |
Why?
|
| Adrenal Glands | 1 | 2020 | 122 | 0.040 |
Why?
|
| Child | 3 | 2020 | 29154 | 0.040 |
Why?
|
| Aorta, Abdominal | 1 | 2020 | 152 | 0.040 |
Why?
|
| Safety Management | 1 | 2020 | 132 | 0.040 |
Why?
|
| Education, Distance | 1 | 2020 | 93 | 0.040 |
Why?
|
| CA-19-9 Antigen | 1 | 2019 | 144 | 0.040 |
Why?
|
| Leucovorin | 1 | 2019 | 332 | 0.040 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2020 | 334 | 0.040 |
Why?
|
| Ilium | 1 | 2018 | 54 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2020 | 272 | 0.040 |
Why?
|
| Albumins | 1 | 2019 | 258 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2023 | 2292 | 0.040 |
Why?
|
| Pattern Recognition, Automated | 1 | 2018 | 125 | 0.040 |
Why?
|
| Cervix Uteri | 1 | 2018 | 253 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 7222 | 0.040 |
Why?
|
| Vaginal Neoplasms | 1 | 2018 | 152 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 390 | 0.040 |
Why?
|
| Vulvar Neoplasms | 1 | 2018 | 236 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2019 | 1391 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2020 | 1014 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2020 | 509 | 0.030 |
Why?
|
| Adenoma | 1 | 2020 | 716 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2017 | 297 | 0.030 |
Why?
|
| Ovary | 1 | 2019 | 668 | 0.030 |
Why?
|
| Logistic Models | 2 | 2013 | 3441 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 527 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2019 | 1944 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2021 | 1283 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2020 | 1301 | 0.030 |
Why?
|
| Communication | 1 | 2021 | 876 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 1742 | 0.030 |
Why?
|
| Ethiodized Oil | 1 | 2013 | 15 | 0.030 |
Why?
|
| Time Factors | 3 | 2013 | 12926 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2013 | 38 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 15694 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2020 | 1335 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 2019 | 1353 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 918 | 0.030 |
Why?
|
| Hepatic Veins | 1 | 2013 | 58 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2018 | 1914 | 0.030 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2013 | 76 | 0.030 |
Why?
|
| Computer Systems | 1 | 2013 | 106 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2021 | 929 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2023 | 2967 | 0.030 |
Why?
|
| Injections, Intra-Arterial | 1 | 2012 | 62 | 0.030 |
Why?
|
| Yttrium Radioisotopes | 1 | 2013 | 178 | 0.030 |
Why?
|
| Infrared Rays | 1 | 2012 | 54 | 0.030 |
Why?
|
| Absorbable Implants | 1 | 2012 | 65 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2013 | 403 | 0.030 |
Why?
|
| Breast | 1 | 2018 | 1344 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 694 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2011 | 173 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2018 | 1360 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1559 | 0.020 |
Why?
|
| Urine | 1 | 2011 | 143 | 0.020 |
Why?
|
| Rabbits | 1 | 2012 | 957 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2018 | 2358 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 1323 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 3981 | 0.020 |
Why?
|
| Pregnancy | 1 | 2023 | 7573 | 0.020 |
Why?
|
| Mutation | 2 | 2021 | 15179 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 690 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2017 | 1270 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2020 | 1375 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 329 | 0.020 |
Why?
|
| Cancer Care Facilities | 1 | 2013 | 884 | 0.020 |
Why?
|
| Transfection | 1 | 2013 | 2944 | 0.020 |
Why?
|
| Dogs | 1 | 2010 | 1155 | 0.020 |
Why?
|
| Genomics | 1 | 2018 | 2738 | 0.020 |
Why?
|
| Animals | 4 | 2013 | 59536 | 0.020 |
Why?
|
| Disease Progression | 1 | 2018 | 6682 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 5637 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 5539 | 0.020 |
Why?
|
| United States | 1 | 2020 | 15433 | 0.010 |
Why?
|
| Biomarkers | 1 | 2013 | 5047 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 4320 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 8865 | 0.010 |
Why?
|
| Texas | 1 | 2011 | 6311 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 6869 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 10331 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 14551 | 0.010 |
Why?
|